Pieris Pharmaceuticals Debt/Equity Ratio 2014-2024 | PVLA

Pieris Pharmaceuticals debt/equity ratio from 2014 to 2024. Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.

Pieris Pharmaceuticals Debt/Equity Ratio 2014-2024 | PVLA

Pieris Pharmaceuticals debt/equity ratio from 2014 to 2024. Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.
Related Stocks
Company NameMarket
Cap
NPK (NPKI)$626M
Performant Healthcare (PHLT)$245M
FTAC Emerald Acquisition (FLDD)$158M
Swiftmerge Acquisition (ANNA)$42M
Insight Acquisition (AMOD)$23M
Hanryu Holdings (GITS)$17M
LQR House (YHC)$11M
ATIF Holdings (ZBAI)$9M
Lion Electric (LEVGQ)$0M